Patterson Companies Inc (PDCO) Return on Assets ROA from the third quarter of 2025 to third quarter of 2024 and for the year 2025, Average High and Low, Fundamental Ratios from Jan 25 2025 to Jan 27 2024 - CSIMarket
CSIMarket
 


Patterson Companies Inc   (NASDAQ: PDCO)


Patterson Companies Inc 's ROA from the third quarter of 2025 to the third quarter of 2024 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Patterson Companies Inc 's ROA in the third quarter of 2025?
Patterson Companies Inc achieved a return on average assets (ROA) of 5.34 % in its third quarter of 2025, which is below Patterson Companies Inc 's average return on assets, which stands at 5.92%.

ROA fell compared to the second quarter of 2025, despite the net income growth of 16.76% from the second quarter of 2025.

However, within the Healthcare sector 144 other companies had a higher return on assets. While return on assets, the total ranking has deteriorated compared to the second quarter of 2025 from 1165 to 1430.

What is ROA?



Return On Assets (Jan 25 2025)
III. Quarter
(Oct 26 2024)
II. Quarter
(Jul 27 2024)
I. Quarter
(Apr 27 2024)
IV. Quarter
(Jan 27 2024)
III. Quarter
Y / Y Total Assets Change -1.74 % -0.1 % -0.89 % -2.02 % -0.31 %
Y / Y Net Income Change -34.51 % -33.02 % -56.19 % -10.56 % -11.61 %
Net Income (TTM) in million 138 155 168 186 193
Return On Assets (TTM) 5.34 % 5.94 % 6.45 % 7.1 % 7.37 %
PDCO's Total Ranking # 1430 # 1165 # 1082 # 1014 # 1120
Total Assets (TTM) in million 2,598 2,604 2,575 2,601 2,644
Seq. Total Assets Change -0.23 % 1.12 % -0.99 % -1.63 % 1.44 %
Seq. Net Income Change 16.76 % 95.73 % -79.63 % 40.65 % 19.42 %



Return On Assets Company Ranking
Within: No.
Industry # 42
Sector # 145
Overall # 1416

Return On Assets Statistics
High Average Low
11.21 %
5.92 %
-19.33 %
(July 29, 2007)   (Jul 25 2020)



  News about Patterson Companies Inc Return on Assets ROA

Patterson Companies (PDCO) Innovating Dental Solutions for Streamlining Patient Experience

Patterson Companies, Inc. (PDCO) has been revolutionizing the dental industry with its commitment to enhancing the patient experience. With recent announcements regarding its subsidiary, Patterson Dental Supply, Inc., and its integration features within Weave and the Patterson Dental practice management software solutions, the company is paving the way for more efficient and streamlined dental practices. Despite the softer year-to-date performance in Patterson Companies Inc shares, the company s dedication to innovation and customer satisfaction positions it as a compelling investment opportunity. Innovative Integration Features for Streamlining Workflow:Patterson Companies, Inc. s subsidiary, Patterson Dental Supply, Inc., is reinforcing its commitment to delivering exceptional dental solutions by introducing new integration features within Weave and the Patterson Dental practice management software solutions. These cutting-edge features aim to streamline the patient experience by enhancing communication, automating administrative tasks, and improving overall workflow efficiency within dental practices. By seamlessly integrating various aspects of dental management, Patterson is empowering dental professionals to spend more time focusing on patient care while reducing administrative burdens.Comparing Patterson Companies, Inc. and Procept Biorobotics Corp Stock:Investors considering Patterson Companies, Inc. or Procept Biorobotics Corp have been faced with the decision of choosing the better investment option. It is crucial to compare these companies on several factors before making any investment decisions. Patterson Companies, Inc. shines through with its commitment to innovation, evident through its recent integration features launch. By continuously enhancing patient experience and streamlining workflow, Patterson Companies, Inc. demonstrates sustainable growth potential and positions itself as an appealing investment prospect.




Financial Statements
Patterson Companies Inc 's Assets $ 2,598 million PDCO's Balance sheet
Patterson Companies Inc 's Income $ 31 million Quarterly PDCO's Income Statement
PDCO's Income by Division See PDCO's Income by Division



Annual Return On Assets (Apr 27 2024)
FY 2024
(Apr 29 2023)
FY 2023
(Apr 30 2022)
FY 2022
(Apr 24 2021)
FY 2021
(Apr 25 2020)
FY 2020
Y / Y Total Assets Change 0.12 % 5.43 % 0.39 % 1.21 % -23.18 %
Total Assets in million 2,601 2,597 2,464 2,454 2,425
Y / Y Net Income Change -10.2 % 2.42 % 30.05 % - -
Net Income in million 186 207 202 155 -589
Annual Return On Assets 7.13 % 7.95 % 8.19 % 6.32 % -24.31 %




Comment on PDCO's ROA in the fiscal year ending 2024
In the fiscal year 2024 Patterson Companies Inc 's ROA decreased compared to previous year to 7.13 %, due to deterioration of net income -10.2 % to $185.52 million, from $206.60 million a year ago, as PDCO's assets were $2,600.54 million.


More Return On Assets Ratios
PDCO's' Return on Assets at Yahoo Finance
Medical Equipment & Supplies Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
PDCO's Roa Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for PDCO's Competitors
Subscribers only: Roa for Patterson Companies Inc 's Suppliers
Subscribers only: Return On Assets for PDCO's Customers

You may also want to know
PDCO's Roi PDCO's Inventory Turnover Ratio PDCO's Growth Rates PDCO's Dividend Comparisons
PDCO's Profitability Ratios PDCO's Asset Turnover Ratio PDCO's Dividend Growth
PDCO's Roe PDCO's Valuation Ratios PDCO's Financial Strength Ratios PDCO's Dividend Payout Ratio



Companies with similar Return On Assets at Jan 25 2025, within Healthcare Sector ROA
Eli Lilly And Company  14.60 %
Gyre Therapeutics Inc   14.53 %
Insulet Corporation  14.40 %
Puma Biotechnology Inc   14.19 %
Waters Corporation  14.11 %
Tenet Healthcare Corp  13.96 %
West Pharmaceutical Services Inc   13.68 %
Intuitive Surgical Inc   13.56 %
Argenx Se  13.43 %
Electromed Inc   13.37 %
Kewaunee Scientific Corporation  13.29 %
Pro dex Inc   12.86 %
Msa Safety Inc  12.86 %
Rigel Pharmaceuticals Inc  12.53 %
Alpha Pro Tech Ltd   12.24 %
Regeneron Pharmaceuticals Inc   12.12 %
Lifevantage Corp  12.06 %
Novartis Ag  11.68 %
Hca Healthcare Inc   11.41 %
Scienture Holdings Inc   11.37 %
Ufp Technologies Inc   11.25 %
Sensus Healthcare Inc   11.20 %
Agilent Technologies inc   11.06 %
Utah Medical Products Inc  10.72 %
Lemaitre Vascular Inc   10.70 %
Amphastar Pharmaceuticals Inc   10.31 %
Filana Therapeutics Inc   9.97 %
Neurocrine Biosciences Inc   9.73 %
Krystal Biotech Inc   9.36 %
3m Company  9.34 %


Date modified: 2026-09-08T15:11:26+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.